Scientific work

Prof. Dr. Siren Sezer

537 publications. The source of the information is stated next to each publication.

Back to profile

  1. Sezer S, Gurlek Demirci B, Guliyev O, Sayin CB, Colak T, Ozdemir Acar FN, Haberal M.

    Source: medicana.com.tr profile page

  2. Transplant Proc. 2015 May;47(4):1182-5. doi: 10.1016/j

    Source: medicana.com.tr profile page

  3. 20Post-transplantation Anemia Predicts Cardiovascular Morbidity and Poor Graft Function in Kidney Transplant Recipients.

    Source: medicana.com.tr profile page

  4. Gurlek Demirci B, Sezer S, Sayin CB, Tutal E, Uyar ME, Ozdemir Acar FN, Haberal M.

    Source: medicana.com.tr profile page

  5. Transplant Proc. 2015 May;47(4):1178-81. doi: 10.1016/

    Source: medicana.com.tr profile page

  6. 21Post-transplant C-reactive protein predicts arterial stiffness and graft function in renal transplant recipients.

    Source: medicana.com.tr profile page

  7. Gurlek Demirci B, Sezer S, Colak T, Sayin CB, Tutal E, Haberal M.

    Source: medicana.com.tr profile page

  8. Transplant Proc. 2015 May;47(4):1174-7. doi: 10.1016/j

    Source: medicana.com.tr profile page

  9. 22High-grade proteinuria as a cardiovascular risk factor in renal transplant recipients.

    Source: medicana.com.tr profile page

  10. Guliyev O, Sayin B, Uyar ME, Genctoy G, Sezer S, Bal Z, Demirci BG, Haberal M.

    Source: medicana.com.tr profile page

  11. Transplant Proc. 2015 May;47(4):1170-3. doi: 10.1016/

    Source: medicana.com.tr profile page

  12. 23Hyperviscosity in renal transplant recipients.

    Source: medicana.com.tr profile page

  13. Tutal E, Erkmen Uyar M, Uyanik S, Bal Z, Guliyev O, Toprak SK, Ilhan O, Sezer S, Haberal M.

    Source: medicana.com.tr profile page

  14. Transplant Proc. 2015 May;47(4):1165-9. doi: 10.1016

    Source: medicana.com.tr profile page

  15. 24Sagittal abdominal diameter as an anthropometric measure of cardiovascular and graft loss risk in renal transplant recipients.

    Source: medicana.com.tr profile page

  16. Bal Z, Uyar ME, Tutal E, Guliyev O, Colak T, Sezer S, Haberal M.

    Source: medicana.com.tr profile page

  17. Transplant Proc. 2015 May;47(4):1162-4. doi: 10.1016/

    Source: medicana.com.tr profile page

  18. 25Post-transplant Hyperuricemıa as a Cardıovascular Risk Factor.

    Source: medicana.com.tr profile page

  19. Erkmen Uyar M, Sezer S, Bal Z, Guliyev O, Tutal E, Kulah E, Genctoy G, Ozdemir Acar N, Haberal M.

    Source: medicana.com.tr profile page

  20. Transplant Proc. 2015 May;47(4):1146-51. doi: 10.1016/

    Source: medicana.com.tr profile page

  21. 26Fibromyalgia and its clinical relevance in renal transplant recipients.

    Source: medicana.com.tr profile page

  22. Erkmen Uyar M, Sezer S, Bal Z, Guliyev O, Tutal E, Genctoy G, Kulah E, Ozdemir Acar N, Haberal M.

    Source: medicana.com.tr profile page

  23. Transplant Proc. 2015 May;47(4):1105-9. doi: 10.1016/

    Source: medicana.com.tr profile page

  24. 27New-onset diabetes and glucose regulation are significant determinants of left ventricular hypertrophy in renal transplant recipients.

    Source: medicana.com.tr profile page

  25. Sezer S, Erkmen Uyar M, Tutal E, Bal Z, Guliyev O, Colak T, Hasdemir E, Haberal M.

    Source: medicana.com.tr profile page

  26. J Diabetes Res. 2015;2015:293896. doi: 10.1155/2015/293896

    Source: medicana.com.tr profile page

  27. 28New-onset diabetes and glucose regulation are significant determinants of left ventricular hypertrophy in renal transplant recipients.

    Source: medicana.com.tr profile page

  28. 29Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia.

    Source: medicana.com.tr profile page

  29. Duman N, Uyanik A, Unsal A, Sezer S, Camsari T, Cirit M, Yilmaz ME, Altun B, Duranay M, Yildiz A, Sahin I, Dogukan A, Ustundag S, Karayaylali I, Kahveci A, Sindel S, Kiykim AA, Yenicerioglu Y, Akbas E, Ozdener F.

    Source: medicana.com.tr profile page

  30. Clin Kidney J. 2014 Oct;7(5):464-9. doi: 10.1093/ckj/sfu079.

    Source: medicana.com.tr profile page

  31. 30Relationship between inflammation and sex hormone profile in female patients receiving different types of renal replacement therapy.Altunoglu A, Yavuz D, Canoz MB, Yavuz R, Karakaş LA, Bayraktar N, Colak T, Sezer S, Ozdemir FN, Haberal M.Transplant Proc. 2014 Jun;46(5):1585-90. doi: 10.1016

    Source: medicana.com.tr profile page

  32. 31Increased frequency of gallbladder stone and related parameters in hemodialysis patients.

    Source: medicana.com.tr profile page

  33. Gençtoy G, Ayidağa S, Ergun T, Lakadamyalı H, Erbayrak M, Sezer S.

    Source: medicana.com.tr profile page

  34. Turk J Gastroenterol. 2014 Feb;25(1):54-8. doi: 10.5152/tjg.2014.4854

    Source: medicana.com.tr profile page

  35. 32Free triiodothyronine in hemodialysis patients: link with malnutrition and inflammation.

    Source: medicana.com.tr profile page

  36. Yavuz D, Sezer S, Yavuz R, Canoz MB, Altunoglu A, Elsürer R, Arat Z, Ozdemir FN.

    Source: medicana.com.tr profile page

  37. Iran J Kidney Dis. 2014 May;8(3):212-7. Erratum in: Iran J Kidney Dis. 2014 Jul;8(4):350

    Source: medicana.com.tr profile page

  38. 33Allopurinol reduces cardiovascular risks and improves renal function in pre-dialysis chronic kidney disease patients with hyperuricemia.Sezer S, Karakan S, Atesagaoglu B, Acar FN.

    Source: medicana.com.tr profile page

  39. Saudi J Kidney Dis Transpl. 2014 Mar;25(2):316-20.PMID:24625997

    Source: medicana.com.tr profile page

  40. 34Differential influence of vitamin D analogs on left ventricular mass index in maintenance hemodialysis patients.

    Source: medicana.com.tr profile page

  41. Sezer S, Tutal E, Bal Z, Uyar ME, Bal U, Cakir U, Acar NO, Haberal M.

    Source: medicana.com.tr profile page

  42. Int J Artif Organs. 2014 Feb;37(2):118-25. doi: 10.5301/ijao.5000289

    Source: medicana.com.tr profile page

  43. 35Long-term oral nutrition supplementation improves outcomes in malnourished patients with chronic kidney disease on hemodialysis.Sezer S, Bal Z, Tutal E, Uyar ME, Acar NO.

    Source: medicana.com.tr profile page

  44. JPEN J Parenter Enteral Nutr. 2014 Nov;38(8):960-5. doi: 10.1177/0148607113517266.

    Source: medicana.com.tr profile page

  45. 36Accumulation of an endogenous inhibitor of nitric oxide synthesis and oxidative DNA damage in end-stage renal disease.Hacişevki A, Gönenç A, Sezer S, Karakan S, Simşek B, Torun M.Clin Lab. 2013;59(11-12):1353-61.

    Source: medicana.com.tr profile page

  46. 37Endothelial nitric oxide synthase polymorphism influences renal allograft outcome.

    Source: medicana.com.tr profile page

  47. Uyar M, Sezer S, Ozdemir FN, Kulah E, Arat Z, Atac FB, Haberal M.

    Source: medicana.com.tr profile page

  48. Clin Transplant. 2014 Feb;28(2):223-8. doi: 10.1111/ctr.12302.

    Source: medicana.com.tr profile page

  49. 38Cytomegalovirus infection in renal transplant recipients: one center's experience.

    Source: medicana.com.tr profile page

  50. Bal Z, Uyar ME, Tutal E, Erdogan E, Colak T, Sezer S, Haberal M.

    Source: medicana.com.tr profile page